title: Intratympanic corticotherapy and tinnitus control after sudden hearing loss.
abstract: BACKGROUND
  Sudden deafness is characterized by an abrupt onset, often idiopathic and tinnitus is present, and becomes the main complaint in up to 80% of patients.
  
  
  OBJECTIVE
  To review carefully all studies of the past 10 years on sudden deafness and tinnitus and analyze the effectiveness of oral and intratympanic steroids for tinnitus control in eight patients with sudden deafness and severe disabling tinnitus.
  
  
  METHODS
  An analytical prospective in which 64 patients after sudden deafness with tinnitus were monitored and 08 of these suffering with severe disabling tinnitus underwent hearing evaluation and application of the Tinnitus Handicap Inventory and Visual Analogue Scale before, during and after sudden deafness treated with oral and intratympanic steroids. It was made a systematic review of publications on the topic in the library of PubMed/MedLine, keywords: Sudden deafness and tinnitus.
  
  
  RESULTS
  Eleven scientific studies were analyzed. Eight patients treated with intratympanic and oral corticosteroids were selected, just two patients showed improvement over the hearing but seven of them showed big improvement in their tinnitus, which was demonstrated by an improvement in the values of the degrees of severity of tinnitus.
  
  
  CONCLUSIONS
  Patients with sudden deafness and severe disabling tinnitus, and underwent intratympanic and oral corticosteroids showed, in this study, significant reduction and/or remission of tinnitus.
authors: Monique Antunes de Souza Chelminski
authors: MA
authors: Barreto
authors: Isabelle Braz de Oliveira
authors: IB
authors: Silva
authors: Carlos Augusto Costa Pires
authors: CA
authors: de Oliveira
authors: Fayez
authors: F
authors: Bahmad
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D005260:Female; D003639:Hearing Loss, Sudden / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D014012:Tinnitus / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014432:Tympanic Membrane
chemical_list: D000305:Adrenal Cortex Hormones; D008775:Methylprednisolone